Related Experiment Video
Updated: Jun 6, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Incidence of infective endocarditis in patients with hypertrophic cardiomyopathy
Somyata Somendra1, Saurabh Mehrotra1, Parag Barwad1
1Department of Cardiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Insights
Infective endocarditis (IE) is rare in hypertrophic cardiomyopathy (HCM) patients, occurring at 0.92 cases per 1000 patient-years. However, IE in HCM significantly increases morbidity and mortality risks.
Area of Science:
- Cardiology
- Infectious Diseases
- Clinical Research
Background:
- Limited data exists on the incidence of infective endocarditis (IE) in patients with hypertrophic cardiomyopathy (HCM).
- This study aimed to determine the IE incidence within a well-defined HCM patient cohort.
Purpose of the Study:
- To evaluate the incidence of infective endocarditis (IE) in patients diagnosed with hypertrophic cardiomyopathy (HCM).
Main Methods:
- Retrospective cohort analysis of 529 HCM patients from May 2003 to June 2023.
- Inclusion criteria required diagnosis of HCM and at least one follow-up visit.
- IE diagnosis after cohort entry was the primary outcome.
Main Results:
- Three out of 529 (0.57%) HCM patients developed IE over 3244.6 total follow-up years.
- The overall incidence of IE in HCM patients was 0.92 per 1000 patient-years.
- IE occurred in both obstructive (1.39/1000 patient-years) and non-obstructive (0.55/1000 patient-years) HCM, with mitral valve involvement leading to severe complications.
Conclusions:
- Infective endocarditis is a rare complication in hypertrophic cardiomyopathy patients.
- Despite its rarity, IE in HCM is associated with significant morbidity and mortality.
Background:
Data on the incidence of infective endocarditis (IE) in patients with hypertrophic cardiomyopathy (HCM) is sparse. This study evaluated a HCM cohort with aim to study the incidence of IE in these patients.
Methods:
All patients entering the HCM cohort from May 2003 to June 2022 of a tertiary care hospital with at least one follow-up visit were included and followed up till June 2023. This was a retrospective cohort analysis. Only individuals who were diagnosed with IE after entry into the cohort were included.
Results:
The study cohort consisted of 529 HCM patients with a total follow up duration of 3244.6 years. The mean and median follow-up durations were 6.1 ± 4.7 and 5.3 (range 31 days to 20.1) years respectively. Three (0.57 %) patients in the cohort developed IE. Incidence of IE in HCM patients was 0.92/1000 patient years. Two patients had left ventricular outflow tract obstruction while one had non-obstructive HCM. None of the patients with isolated mid-cavity gradients developed IE. The incidence of IE in the obstructive and nonobstructive groups was 1.39 and 0.55 per 1000 patient years respectively. Two had vegetations on mitral valve while one had vegetations on aortic valve. Both patients with mitral valve endocarditis developed severe residual mitral regurgitation and heart failure.
Conclusions:
IE is a rare complication in HCM patients with an incidence of 0.92/1000 patient years. However, when it occurs, IE is associated with high morbidity and mortality.
Related Concept Videos
Endocarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Endocarditis II: Clinical features and Diagnostic Tests
Endocarditis III: Medical Management
Myocarditis I: Introduction
Myocarditis III: Medical Management

